Ipsilateral transient amaurosis, mydriasis and light reflex absence after subconjunctival local anesthesia with mepivacaine in three patients with refractory glaucoma - a case report.
Aged
Anesthesia, Local
/ methods
Anesthetics, Local
/ administration & dosage
Blindness
/ chemically induced
Ciliary Body
/ surgery
Conjunctiva
/ drug effects
Glaucoma, Open-Angle
/ surgery
Humans
Injections, Intraocular
Intraocular Pressure
Laser Coagulation
Male
Mepivacaine
/ administration & dosage
Middle Aged
Mydriasis
/ chemically induced
Pupil Disorders
/ chemically induced
Amaurosis
Cyclophotocoagulation
Glaucoma
Mepivacaine
Mydriasis
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
28 Aug 2019
28 Aug 2019
Historique:
received:
21
06
2019
accepted:
15
08
2019
entrez:
29
8
2019
pubmed:
29
8
2019
medline:
28
12
2019
Statut:
epublish
Résumé
The subconjunctival anesthesia with local anesthetics is considered as a low-risk procedure allowing ocular surgery without serious complications typical for retro- or parabulbar anesthesia, especially in patients with preexisting Optic Nerve damage. We report development of ipsilateral transient amaurosis accompanied with mydriasis and both, direct and consensual light response absence. Three patients with advanced refractory glaucoma undergoing laser cyclophotocoagulation (CPC) for intraocular pressure lowering experienced these adverse effects just few minutes after subconjunctival injection of mepivacaine 2% solution (Scandicaine® 2%, without vasoconstrictor supplementation). The vision was completely recovered to usual values in up to 20 h after mepivacaine application. Extensive ophthalmological examination, including cranial magnetic resonance imaging (MRI), revealed no further ocular abnormalities, especially no vascular constriction or thrombotic signs as well as no retinal detachment. The oculomotor function remained intact. The blockade of ipsilateral ciliary ganglion parasympathetic fibers by mepivacaine may be the responsible mechanism. Systemic pathways as drug-drug interactions seem to be unlikely involved. Importantly, all three patients tolerated the same procedure previously or at a later date without any complication. Overall, our thoroughly elaborated risk management could not determine the causative factor explaining the observed ocular complications just in the current occasion and not at other time points. Doctors should be aware and patients should be informed about such rare complications after subconjunctival local anesthetics administration. Adequate risk management should insure patients' safety.
Sections du résumé
BACKGROUND
BACKGROUND
The subconjunctival anesthesia with local anesthetics is considered as a low-risk procedure allowing ocular surgery without serious complications typical for retro- or parabulbar anesthesia, especially in patients with preexisting Optic Nerve damage. We report development of ipsilateral transient amaurosis accompanied with mydriasis and both, direct and consensual light response absence.
CASE PRESENTATION
METHODS
Three patients with advanced refractory glaucoma undergoing laser cyclophotocoagulation (CPC) for intraocular pressure lowering experienced these adverse effects just few minutes after subconjunctival injection of mepivacaine 2% solution (Scandicaine® 2%, without vasoconstrictor supplementation). The vision was completely recovered to usual values in up to 20 h after mepivacaine application. Extensive ophthalmological examination, including cranial magnetic resonance imaging (MRI), revealed no further ocular abnormalities, especially no vascular constriction or thrombotic signs as well as no retinal detachment. The oculomotor function remained intact. The blockade of ipsilateral ciliary ganglion parasympathetic fibers by mepivacaine may be the responsible mechanism. Systemic pathways as drug-drug interactions seem to be unlikely involved. Importantly, all three patients tolerated the same procedure previously or at a later date without any complication. Overall, our thoroughly elaborated risk management could not determine the causative factor explaining the observed ocular complications just in the current occasion and not at other time points.
CONCLUSIONS
CONCLUSIONS
Doctors should be aware and patients should be informed about such rare complications after subconjunctival local anesthetics administration. Adequate risk management should insure patients' safety.
Identifiants
pubmed: 31455285
doi: 10.1186/s12886-019-1202-2
pii: 10.1186/s12886-019-1202-2
pmc: PMC6712733
doi:
Substances chimiques
Anesthetics, Local
0
Mepivacaine
B6E06QE59J
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
195Subventions
Organisme : Volkswagen Foundation
ID : Niedersachsen Vorab
Références
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Jul;90(1):21-4
pubmed: 10884631
Klin Monbl Augenheilkd. 2000 Nov;217(5):296-8
pubmed: 11146829
Dtsch Zahnarztl Z. 1991 Dec;46(12):834-6
pubmed: 1817903
Natl J Maxillofac Surg. 2011 Jan;2(1):82-5
pubmed: 22442617
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jun;113(6):e1-5
pubmed: 22677022
J Endod. 2013 Dec;39(12):1654-7
pubmed: 24238467
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Mar;121(3):e39-50
pubmed: 26768073
Hautarzt. 1987 Sep;38(9):544-7
pubmed: 3692857
Am J Ophthalmol. 1986 Jun 15;101(6):688-90
pubmed: 3717252
Arch Ophthalmol. 1985 Sep;103(9):1337-9
pubmed: 4038126
Am J Ophthalmol. 1980 Sep;90(3):422-4
pubmed: 7425061
Ophthalmology. 1995 Mar;102(3):501-9
pubmed: 7891991
SADJ. 1998 May;53(5):235-8
pubmed: 9760939